Form 4 for LENZ LENZ Therapeutics, Inc.
Accepted 2025-03-07 00:00:00 ET · period of report 2025-03-07 · accession 0001815776-25-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-07 | 2025-03-07 | LENZ | Schimmelpennink Evert B. | Pres, CEO, Sec, Dir | M - OptEx | $1.04 | +4,200 | 49.2K | +9% | +$4,368 |
| D | 2025-03-07 | 2025-03-07 | LENZ | Schimmelpennink Evert B. | Pres, CEO, Sec, Dir | M - OptEx | $0.00 | -4,200 | 337.9K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-07 | M | A | 4,200 | $1.04 | 49,200 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2025-03-07 | M | D | 4,200 | $0.00 | 337,906 | D | $1.04 · — to 2031-03-07 | 4,200 Common Stock | (F1) Shares issued pursuant to the LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.) 2020 Equity Incentive Plan (the "2020 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2020 Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 8, 2021. |